Forbion and Gimv co-lead €72m series-A financing round in Complement Therapeutics
Germany-headquartered early-stage biotech company Complement Therapeutics has announced the closing of a €72m series-A financing round led by Gimv together with existing investor Forbion, a life sciences venture capital firm based...